Civic Intelligence

International Medica Foundation

990PF • Fiscal year 2015 • EIN 26-1556795

Dec 01, 2014 to Nov 30, 2015 • Filed on Jun 23, 2016

421 1st Ave SW Suite 304Rochester, MN 55903

(507) 206-4380

Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

78th percentile

0.49x

Higher debt load relative to assets than 78% of similar nonprofits.

2015 filings • 501(c)3 • $1M-$5M nonprofits • Source year 2015

Liabilities / Revenue

72nd percentile

0.36x

Higher debt load relative to revenue than 72% of similar nonprofits.

2015 filings • 501(c)3 • $1M-$5M nonprofits • Source year 2015

Net Margin

93rd percentile

54%

Higher net margin than 93% of similar nonprofits.

2015 filings • 501(c)3 • $1M-$5M nonprofits • Source year 2015

Top Officer Pay

93rd percentile

$253,315

Higher top officer pay than 93% of similar nonprofits.

Top officer pay equals 18.0% of source-year revenue.

2015 filings • 501(c)3 • $1M-$5M nonprofits • Source year 2015

Asset Growth

98th percentile

306%

Faster asset growth than 98% of similar nonprofits.

2015 filings • 501(c)3 • $1M-$5M nonprofits • Annualized from 2014 to 2015

Revenue Growth

100th percentile

6692643%

Faster revenue growth than 100% of similar nonprofits.

2015 filings • 501(c)3 • $1M-$5M nonprofits • Annualized from 2014 to 2015

Assets

Up

$1,013,673

Up $763,848 (+306%) from 2014

Net Assets

Up

$513,673

Up $763,848 (+305%) from 2014

Liabilities

Flat

$500,000

Flat from 2014

Revenue

Up

$1,405,476

Up $1,405,455 (+6692643%) from 2014

Expenses

Up

$641,628

Up $481,372 (+300%) from 2014

Net Income

Up

$763,848

Up $924,083 (+577%) from 2014

Historical Trend

Balance Sheet Trend

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$2.0M$1.0M$0-$1.0MAssets 2010: $1,961,849Liabilities 2010: $0Net Assets 2010: $1,961,8492010Assets 2012: $518,547Liabilities 2012: $500,000Net Assets 2012: $18,5472012Assets 2013: $346,679Liabilities 2013: $610,000Net Assets 2013: -$263,3212013Assets 2014: $249,825Liabilities 2014: $500,000Net Assets 2014: -$250,1752014Assets 2015: $1,013,673Liabilities 2015: $500,000Net Assets 2015: $513,6732015Assets 2016: $626,403Liabilities 2016: $500,000Net Assets 2016: $126,4032016Assets 2017: $159,208Liabilities 2017: $500,000Net Assets 2017: -$340,7922017Assets 2018: $63,726Liabilities 2018: $500,000Net Assets 2018: -$436,2742018Assets 2019: $72,478Liabilities 2019: $500,000Net Assets 2019: -$427,5222019

Highlighted filing

2015

Assets$1,013,673
Liabilities$500,000
Net Assets$513,673

Operations Trend

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$4.0M$3.0M$2.0M$1.0M$0-$1.0MExpenses 2010: $3,321,3212010Expenses 2012: $724,9282012Expenses 2013: $581,9212013Revenue 2014: $21Expenses 2014: $160,256Net Income 2014: -$160,2352014Revenue 2015: $1,405,476Expenses 2015: $641,628Net Income 2015: $763,8482015Revenue 2016: $19,413Expenses 2016: $406,683Net Income 2016: -$387,2702016Revenue 2017: $106,420Expenses 2017: $573,615Net Income 2017: -$467,1952017Revenue 2018: $105,241Expenses 2018: $200,723Net Income 2018: -$95,4822018Revenue 2019: $107,006Expenses 2019: $98,254Net Income 2019: $8,7522019

Highlighted filing

2015

Revenue$1,405,476
Expenses$641,628
Net Income$763,848
Jump To
Filing Snapshot
Filing Period
Dec 1, 2014 to Nov 30, 2015
Signed
Jun 23, 2016
Return Version
2014v6.0
Compensation and Service Providers

Employees

NameTitleFull / Part TimeBaseOtherTotal
DR LEONARD RUIZPresidentFT$230,000$23,315$253,315
SCOTT ROSENOWVP/Treasurer/SecretaryFT$202,625$19,702$222,327
DR FRANKLIN G PRENDERGASTChairman-$0--
DR STEVEN G REEDDirector-$0--
DR RICHARD HAUGLANDDirector-$0--
DR ER DICKSONDirector-$0--
Filing and Contact Details

Filer

Filer Name
International Medica Foundation
EIN
26-1556795
Phone
5072064380
Address
421 1ST AVE SW SUITE 304, ROCHESTER, MN 55903

Signing Officer

Name
Dr Leonard Ruiz
Title
President
Phone
5072064380
Signed
2016-06-23
Discuss with paid preparer
Yes

Preparer

Firm
Smith Schafer and Assoc Ltd
Address
220 SOUTH BROADWAY SUITE 102, ROCHESTER, MN 55904
Preparer
Thomas H Wente
Phone
5072883277
Raw XML AppendixShowing 400 of 434 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
AccountingFeesSchedule/AccountingFeesDetail/AdjustedNetIncomeAmt00
AccountingFeesSchedule/AccountingFeesDetail/Amt02500
AccountingFeesSchedule/AccountingFeesDetail/CategoryTxt0ACCOUNTING
AccountingFeesSchedule/AccountingFeesDetail/DisbursementsCharitablePrpsAmt02000
AccountingFeesSchedule/AccountingFeesDetail/NetInvestmentIncomeAmt0500
DepreciationSchedule/DepreciationPropertyGrp/AcquiredDt02010-09-20
DepreciationSchedule/DepreciationPropertyGrp/AcquiredDt12012-12-26
DepreciationSchedule/DepreciationPropertyGrp/AdjustedNetIncomeAmt00
DepreciationSchedule/DepreciationPropertyGrp/AdjustedNetIncomeAmt10
DepreciationSchedule/DepreciationPropertyGrp/ComputationMethodTxt0200DB
DepreciationSchedule/DepreciationPropertyGrp/ComputationMethodTxt1200DB
DepreciationSchedule/DepreciationPropertyGrp/CostOrOtherBasisAmt01126
DepreciationSchedule/DepreciationPropertyGrp/CostOrOtherBasisAmt11990
DepreciationSchedule/DepreciationPropertyGrp/CurrentYearExpenseAmt00
DepreciationSchedule/DepreciationPropertyGrp/CurrentYearExpenseAmt1295
DepreciationSchedule/DepreciationPropertyGrp/LifeRt03.000000000000
DepreciationSchedule/DepreciationPropertyGrp/LifeRt13.000000000000
DepreciationSchedule/DepreciationPropertyGrp/NetInvestmentIncomeAmt00
DepreciationSchedule/DepreciationPropertyGrp/NetInvestmentIncomeAmt10
DepreciationSchedule/DepreciationPropertyGrp/PriorYearDepreciationAmt01126
DepreciationSchedule/DepreciationPropertyGrp/PriorYearDepreciationAmt11547
DepreciationSchedule/DepreciationPropertyGrp/PropertyDesc0SONY COMPUTER
DepreciationSchedule/DepreciationPropertyGrp/PropertyDesc1LENOVO COMPUTER
GeneralExplanationAttachment/GeneralExplanationGrp/FormAndLineReferenceDesc0FORM 990-PF, PART IX-A, #1-SUMMARY OF DIRECT CHARITABLE ACTIVITIES
GeneralExplanationAttachment/GeneralExplanationGrp/FormAndLineReferenceDesc1FORM 990-PF, PART IX-A, #2-SUMMARY OF DIRECT CHARITABLE ACTIVITIES
GeneralExplanationAttachment/GeneralExplanationGrp/FormAndLineReferenceDesc2FORM 990-PF, PART 1X-A, #3-SUMMARY OF DIRECT CHARITABLE ACTIVITIES
GeneralExplanationAttachment/GeneralExplanationGrp/MediumExplanationTxt0CONTINUATION OF DIRECT CHARITABLE ACTIVITY #1:ROTAVIRUS VACCINE ACTIVITIES: BRIEF HISTORY: THE ROTAVIRUS VACCINE, KNOWN AS ROTASHIELD, WAS INVENTED AND INITIALLY DEVELOPED BY THE NATIONAL INSTITUTES OF HEALTH OF THE UNITED STATES ("NIH"). FROM ITS INCEPTION IN DECEMBER 2007 AND CONTINUING CURRENTLY, INTERNATIONAL MEDICA PERSONNEL HAVE BEEN WORKING EXTENSIVELY ALONGSIDE THE NIH AND A VACCINE MANUFACTURER TO COMPLETE A FINALIZED VACCINE PRODUCT ULTIMATELY FOR USE IN THE NEGLECTED POPULATIONS OF THE WORLD. VACCINE MANUFACTURED FOR CLINICAL TRIALS WAS TESTED TO ENSURE IT MET ALL POTENCY STANDARDS AND ALL REGULATORY REQUIREMENTS PRIOR TO BEING RELEASED FOR USE. INTERNATIONAL MEDICA, WORKING WITH THE NIH, ACTIVELY PARTICIPATED IN THE ONGOING DEVELOPMENT OF THE MANUFACTURING PROCESS, ENSURING THAT ANY CHANGES TO THE MANUFACTURING PROCESS MET ALL REGULATORY REQUIREMENTS. PHASE II CLINICAL TRIAL: OVERVIEW: WORKING WITH A NUMBER OF GROUPS INTERNATIONALLY, THE FOUNDATION CONDUCTED A PHASE II CLINICAL TRIAL THE PURPOSE OF WHICH WAS TO ALLOW INTERNATIONAL MEDICA TO DETERMINE IF THE ROTASHIELD VACCINE, WHEN GIVEN IN THE NEONATAL DELIVERY REGIMEN, STIMULATES THE IMMUNE RESPONSE OF INFANTS TO PROVIDE AN ADEQUATE PROTECTION AGAINST THE ROTAVIRUS. GIVING THE VACCINE TO NEONATES WOULD ALLOW MORE CHILDREN TO RECEIVE THE VACCINE, AS CHILDREN IN DEVELOPING COUNTRIES ARE MOST LIKELY TO HAVE INTERACTION WITH HEALTH CARE PROVIDERS IN THE FIRST DAYS IMMEDIATELY AFTER BIRTH. STARTING IMMUNIZATIONS AT OR NEAR BIRTH WOULD ALSO PROTECT INFANTS EARLIER IN LIFE.SPECIFICS: IN EARLY 2ND QUARTER OF 2009, MANUFACTURE OF THE FINAL ROTASHIELD VACCINE WAS COMPLETED AND READY FOR THE CLINICAL TRIAL. THIS PHASE II CLINICAL TRIAL ULTIMATELY SCREENED APPROXIMATELY 1,051 CHILDREN FOR THE TRIAL WITH MULTI-ARM END-POINTS. A TOTAL OF 949 INFANTS COMPLETED THE STUDY AND PURSUANT TO THE TRIAL DESIGN WERE FOLLOWED FOR ONE-YEAR TO MONITOR FOR ANY SAFETY ISSUES. THE LAST INFANT FOLLOW-UP VISIT WAS COMPLETED IN EARLY DECEMBER 2010. AFTER A YEAR OF FOLLOWING THE INFANTS, THERE WAS THEN A DATA LOCK ON THE CLINICAL TRIAL INFORMATION IN JUNE OF 2011 FOLLOWED BY THE FINAL CLINICAL STUDY REPORT IN DECEMBER OF 2011. NEO-NATAL DOSING: AS MENTIONED ABOVE, A KEY ASPECT OF INTL-MEDICA'S DEVELOPMENT OF ROTASHIELD WAS THE CHANGE OF DOSING FOR ROTAVIRUS VACCINES TO A NEONATAL DOSING SCHEDULE, I.E. PROVIDING THE FIRST DOSE WITHIN THE FIRST 29 DAYS OF LIFE AND A SECOND DOSE BEFORE 60 DAYS OF AGE. THE VACCINE WAS ORIGINALLY DEVELOPED WHERE THE FIRST DOSE WOULD BE ADMINISTERED TO INFANTS AT 2 MONTHS OF AGE, IN A THREE DOSE REGIMEN. TO INCREASE THE EFFECTIVENESS OF THE VACCINE WITH FEWER DOSES, AND TO INCREASE THE LIKELIHOOD OF ACCESS OF CHILDREN TO HEALTH PROFESSIONALS IN THE DEVELOPING WORLD, INTERNATIONAL MEDICA DID EXTENSIVE REVIEW INTO THE PREVIOUS DATA AND ESTABLISHED A PROTOCOL TO DETERMINE THE EFFECTIVENESS OF ROTASHIELD WHEN GIVEN IN THIS TWO-DOSE, NEONATAL DELIVERY REGIME. NEONATAL DOSING HAS BECOME A PRACTICE OF GREAT INTEREST IN THE PEDIATRIC VACCINE FIELDS SINCE A SIGNIFICANT NUMBER OF INFANTS DIE FROM VACCINE PREVENTABLE DISEASES WITHIN THE FIRST FEW MONTHS OF LIFE; AND IN THE DEVELOPING WORLD, MOST INFANTS COME IN CONTACT WITH MEDICAL/HEALTH WORKERS PRIMARILY DURING THE NEONATAL PERIOD.FURTHER, AS ALL ROTAVIRUS VACCINES HAVE AN INCREASED RISK OF VACCINE-ASSOCIATED INTUSSUSCEPTION AFTER RECEIVING THE VACCINE, PROVIDING THE VACCINE PRIOR TO THE AGE WHERE INTUSSUSCEPTION IS TO OCCUR (NEONATAL PERIOD) COULD MINIMIZE IF NOT ELIMINATE THE RISK OF INTUSSUSCEPTION. THIS COULD LEAD TO ROTASHIELD ACTUALLY BEING THE SAFEST ROTAVIRUS VACCINE ON THE MARKET.NEW RIGHTS: CONSISTENT WITH OUR NEONATAL DELIVERY STRATEGY, INTL-MEDICA, WORKING WITH THE NIH, AMENDED OUR LICENSE TO ADD THE INTELLECTUAL PROPERTY THAT THE NIH HAS DEVELOPED CONCERNING NEO-NATAL DELIVERY OF ROTASHIELD. IN ESSENCE, THE CLINICAL TRIAL CONDUCTED BY INTL-MEDICA PROVED THE PATENTED IDEAS OF THE NIH OF NEONATAL DOSING.PHASE II TRIA
GeneralExplanationAttachment/GeneralExplanationGrp/MediumExplanationTxt1CONTINUATION OF SUMMARY OF DIRECT CHARITABLE ACTIVITY #2:A TYPICAL LIQUID ROTAVIRUS SUSPENSION WOULD GENERALLY LOSE ITS EFFECTIVENESS AFTER APPROXIMATELY ONE WEEK OF STORAGE AT 37 C (98.6 F), WHEREAS THE NEW ROTASHIELD LIQUID FORMULATION HAS SHOWN STABILITY FOR 6 MONTHS AT THIS TEMPERATURE EVEN WHEN AN ANTACID IS PRESENT.. THIS SAME PROPRIETARY TECHNOLOGY MAY BE ADAPTABLE FOR USE WITH OTHER ORAL VACCINES. THE FOUNDATION HAS BEEN ACTIVELY SEEKING INTELLECTUAL PROPERTY PROTECTION OF ITS ADVANCED FORMULATION.INTL-MEDICA EXPANDED ITS PATENT PROTECTION OF ITS NEW FORMULATION AND FILED FOR EXTENSIVE WORLD-WIDE PATENT PROTECTION OF ITS FORMULATION. WE ALSO SIGNED A LICENSE FOR OUR "ELIMINATION OF THE REFRIGERATION (COLD CHAIN) REQUIREMENTS" TECHNOLOGY WITH A COMPANY THAT IS COMPRISED OF EXPERTS IN VACCINES, INCLUDING THE DELIVERY OF VACCINES. THIS COMPANY, WITH OUR SUPPORT, IS ACTIVELY DEVELOPING THAT TECHNOLOGY PLATFORM. FY DECEMBER 2014-NOVEMBER 2015 UPDATE: INTL-MEDIA CONTINUES TO PROVIDE A STRONG LEADERSHIP ROLE IN THE FORMULATION DEVELOPMENT. ONGOING RESEARCH TO DEAL WITH COMPLEX MANUFACTURING ISSUES E.G. LYOPHILIZATION AND PRODUCING MINIMIZE PARTICLE SIZES AND MINIMIZING MOISTURE IS ONGOING. WE CONTINUE TO ACTIVELY PROSECUTE OUR PATENT PROTECTION FOR THIS TECHNOLOGY AROUND THE WORLD.
GeneralExplanationAttachment/GeneralExplanationGrp/MediumExplanationTxt2CONTINUATION OF SUMMARY OF DIRECT CHARITABLE ACTIVITY #3:IT HAS SHOWN PROMISE IN IN VITRO TESTING AND THE RESULTS WOULD INDICATE POTENTIAL FOR EFFECTIVE TREATMENT OF MALARIA, AND VERY IMPORTANTLY, ITS MECHANISM OF ACTION MAY PRECLUDE THE DEVELOPMENT OF "DRUG RESISTANCE" AS IS OCCURRING WITH CURRENT MALARIA TREATMENTS. THIS PROJECT FIT OUR HUMANITARIAN FOCUS, AS THROUGH OUR INVOLVEMENT WE ALSO GAINED RIGHTS TO USE THIS TREATMENT IN THE NEGLECTED POPULATIONS OF THE WORLD. WE BROUGHT OUR INVOLVEMENT IN THE PROJECT TO A CLOSE AT THE END OF THE YEAR AFTER TAKING A LEADERSHIP ROLE IN ENSURING THAT THE MINISTER OF HEALTH IN VIETNAM APPROVED THE REVISED PROTOCOL AND SUPPORTING DOCUMENTS ALLOWING THE ENROLLMENT OF PATIENTS TO MOVE FORWARD. THESE SAME DOCUMENTS WE HELPED DEVELOP WERE PROVIDED TO THE IRB AT PURDUE UNIVERSITY FOR THEIR APPROVAL. INTERNATIONAL MEDICA PLAYED A KEY ROLE IN HELPING TO MOVE A TECHNOLOGY FORWARD WHICH MAY HAVE SIGNIFICANT HUMANITARIAN BENEFIT AT SOME POINT IN THE FUTURE AS WORK CONTINUES ON THIS PARTICULAR DRUG PRODUCT. INTL - MEDICA ALSO OBTAINED A RIGHT OF FIRST REFUSAL FOR HUMANITARIAN USE OF THIS TREATMENT IN THE DEVELOPING WORLD SHOULD IT BECOME SUCCESSFUL.
IRS990PF/AddressChangeInd0X
IRS990PF/AnalysisIncomeProducingActyGrp/IntOnSavAndTempCashInvstGrp/ExclusionAmt057
IRS990PF/AnalysisIncomeProducingActyGrp/IntOnSavAndTempCashInvstGrp/ExclusionCd014
IRS990PF/AnalysisIncomeProducingActyGrp/OtherInvestmentIncmPartVIIGrp/RelatedOrExemptFunctionIncmAmt01405419
IRS990PF/AnalysisIncomeProducingActyGrp/SubtotalsIncmProducingActyGrp/ExclusionAmt057
IRS990PF/AnalysisIncomeProducingActyGrp/SubtotalsIncmProducingActyGrp/RelatedOrExemptFunctionIncmAmt01405419
IRS990PF/AnalysisIncomeProducingActyGrp/SubtotalsIncmProducingActyGrp/UnrelatedBusinessTaxblIncmAmt00
IRS990PF/AnalysisIncomeProducingActyGrp/TotalIncomeProducingActyAmt01405476
IRS990PF/AnalysisOfRevenueAndExpenses/AccountingFeesAdjNetIncmAmt00
IRS990PF/AnalysisOfRevenueAndExpenses/AccountingFeesChrtblPrpsAmt02000
IRS990PF/AnalysisOfRevenueAndExpenses/AccountingFeesNetInvstIncmAmt0500
IRS990PF/AnalysisOfRevenueAndExpenses/AccountingFeesRevAndExpnssAmt02500
IRS990PF/AnalysisOfRevenueAndExpenses/AdjustedNetIncomeAmt00
IRS990PF/AnalysisOfRevenueAndExpenses/CapGainNetIncmNetInvstIncmAmt00
IRS990PF/AnalysisOfRevenueAndExpenses/CompOfcrDirTrstAdjNetIncmAmt00
IRS990PF/AnalysisOfRevenueAndExpenses/CompOfcrDirTrstDsbrsChrtblAmt0380513
IRS990PF/AnalysisOfRevenueAndExpenses/CompOfcrDirTrstNetInvstIncmAmt095128
IRS990PF/AnalysisOfRevenueAndExpenses/CompOfcrDirTrstRevAndExpnssAmt0475641
IRS990PF/AnalysisOfRevenueAndExpenses/ContriPaidDsbrsChrtblAmt00
IRS990PF/AnalysisOfRevenueAndExpenses/ContriPaidRevAndExpnssAmt00
IRS990PF/AnalysisOfRevenueAndExpenses/DeprecAndDpltnAdjNetIncmAmt00
IRS990PF/AnalysisOfRevenueAndExpenses/DeprecAndDpltnNetInvstIncmAmt0295
IRS990PF/AnalysisOfRevenueAndExpenses/DeprecAndDpltnRevAndExpnssAmt0295
IRS990PF/AnalysisOfRevenueAndExpenses/ExcessRevenueOverExpensesAmt0763848
IRS990PF/AnalysisOfRevenueAndExpenses/InterestOnSavNetInvstIncmAmt057
IRS990PF/AnalysisOfRevenueAndExpenses/InterestOnSavRevAndExpnssAmt057
IRS990PF/AnalysisOfRevenueAndExpenses/LegalFeesAdjNetIncmAmt00
IRS990PF/AnalysisOfRevenueAndExpenses/LegalFeesDsbrsChrtblAmt022606
IRS990PF/AnalysisOfRevenueAndExpenses/LegalFeesNetInvstIncmAmt00
IRS990PF/AnalysisOfRevenueAndExpenses/LegalFeesRevAndExpnssAmt022606
IRS990PF/AnalysisOfRevenueAndExpenses/NetInvestmentIncomeAmt01295773
IRS990PF/AnalysisOfRevenueAndExpenses/NetSTCapitalGainAdjNetIncmAmt00
IRS990PF/AnalysisOfRevenueAndExpenses/OccupancyAdjNetIncmAmt00
IRS990PF/AnalysisOfRevenueAndExpenses/OccupancyDsbrsChrtblAmt07973
IRS990PF/AnalysisOfRevenueAndExpenses/OccupancyNetInvstIncmAmt0131
IRS990PF/AnalysisOfRevenueAndExpenses/OccupancyRevAndExpnssAmt08104
IRS990PF/AnalysisOfRevenueAndExpenses/OtherExpensesAdjNetIncmAmt00
IRS990PF/AnalysisOfRevenueAndExpenses/OtherExpensesDsbrsChrtblAmt091156
IRS990PF/AnalysisOfRevenueAndExpenses/OtherExpensesNetInvstIncmAmt08112
IRS990PF/AnalysisOfRevenueAndExpenses/OtherExpensesRevAndExpnssAmt099268
IRS990PF/AnalysisOfRevenueAndExpenses/OtherIncomeAdjNetIncmAmt00
IRS990PF/AnalysisOfRevenueAndExpenses/OtherIncomeNetInvstIncmAmt01405419
IRS990PF/AnalysisOfRevenueAndExpenses/OtherIncomeRevAndExpnssAmt01405419
IRS990PF/AnalysisOfRevenueAndExpenses/OtherProfFeesAdjNetIncmAmt00
IRS990PF/AnalysisOfRevenueAndExpenses/OtherProfFeesDsbrsChrtblAmt01034
IRS990PF/AnalysisOfRevenueAndExpenses/OtherProfFeesNetInvstIncmAmt0259
IRS990PF/AnalysisOfRevenueAndExpenses/OtherProfFeesRevAndExpnssAmt01293
IRS990PF/AnalysisOfRevenueAndExpenses/ScheduleBNotRequiredInd0X
IRS990PF/AnalysisOfRevenueAndExpenses/TaxesAdjNetIncmAmt00
IRS990PF/AnalysisOfRevenueAndExpenses/TaxesDsbrsChrtblAmt021114
IRS990PF/AnalysisOfRevenueAndExpenses/TaxesNetInvstIncmAmt05278
IRS990PF/AnalysisOfRevenueAndExpenses/TaxesRevAndExpnssAmt026392
IRS990PF/AnalysisOfRevenueAndExpenses/TotalAdjNetIncmAmt00
IRS990PF/AnalysisOfRevenueAndExpenses/TotalExpensesAdjNetIncmAmt00
IRS990PF/AnalysisOfRevenueAndExpenses/TotalExpensesDsbrsChrtblAmt0531925
IRS990PF/AnalysisOfRevenueAndExpenses/TotalExpensesNetInvstIncmAmt0109703
IRS990PF/AnalysisOfRevenueAndExpenses/TotalExpensesRevAndExpnssAmt0641628
IRS990PF/AnalysisOfRevenueAndExpenses/TotalNetInvstIncmAmt01405476
IRS990PF/AnalysisOfRevenueAndExpenses/TotalRevAndExpnssAmt01405476
IRS990PF/AnalysisOfRevenueAndExpenses/TotOprExpensesAdjNetIncmAmt00
IRS990PF/AnalysisOfRevenueAndExpenses/TotOprExpensesDsbrsChrtblAmt0531925
IRS990PF/AnalysisOfRevenueAndExpenses/TotOprExpensesNetInvstIncmAmt0109703
IRS990PF/AnalysisOfRevenueAndExpenses/TotOprExpensesRevAndExpnssAmt0641628
IRS990PF/AnalysisOfRevenueAndExpenses/TravConfMeetingAdjNetIncmAmt00
IRS990PF/AnalysisOfRevenueAndExpenses/TravConfMeetingDsbrsChrtblAmt05529
IRS990PF/AnalysisOfRevenueAndExpenses/TravConfMeetingNetInvstIncmAmt00
IRS990PF/AnalysisOfRevenueAndExpenses/TravConfMeetingRevAndExpnssAmt05529
IRS990PF/ChgInNetAssetsFundBalancesGrp/ExcessRevenueOverExpensesAmt0763848
IRS990PF/ChgInNetAssetsFundBalancesGrp/OtherDecreasesAmt00
IRS990PF/ChgInNetAssetsFundBalancesGrp/OtherIncreasesAmt00
IRS990PF/ChgInNetAssetsFundBalancesGrp/SubtotalAmt0513673
IRS990PF/ChgInNetAssetsFundBalancesGrp/TotNetAstOrFundBalancesBOYAmt0-250175
IRS990PF/ChgInNetAssetsFundBalancesGrp/TotNetAstOrFundBalancesEOYAmt0513673
IRS990PF/DistributableAmountGrp/Sect4942j3j5FndtnAndFrgnOrgInd0X
IRS990PF/ExciseTaxBasedOnInvstIncmGrp/AppliedToEsTaxAmt020000
IRS990PF/ExciseTaxBasedOnInvstIncmGrp/AppliedToESTaxAmt02500
IRS990PF/ExciseTaxBasedOnInvstIncmGrp/DomesticOrgMeetingSect4940eInd0X
IRS990PF/ExciseTaxBasedOnInvstIncmGrp/EsPenaltyAmt0121
IRS990PF/ExciseTaxBasedOnInvstIncmGrp/EstimatedPlusOvpmtIncmTxAmt06000
IRS990PF/ExciseTaxBasedOnInvstIncmGrp/Form2220AttachedInd0X
IRS990PF/ExciseTaxBasedOnInvstIncmGrp/InvestmentIncomeExciseTaxAmt012958
IRS990PF/ExciseTaxBasedOnInvstIncmGrp/OverpaymentAmt012921
IRS990PF/ExciseTaxBasedOnInvstIncmGrp/RefundAmt010421
IRS990PF/ExciseTaxBasedOnInvstIncmGrp/SubtitleATaxAmt00
IRS990PF/ExciseTaxBasedOnInvstIncmGrp/SubtotalAmt012958
IRS990PF/ExciseTaxBasedOnInvstIncmGrp/TaxBasedOnInvestmentIncomeAmt012958
IRS990PF/ExciseTaxBasedOnInvstIncmGrp/TaxUnderSection511Amt00
IRS990PF/ExciseTaxBasedOnInvstIncmGrp/TotalPaymentsAndCreditsAmt026000
IRS990PF/FMVAssetsEOYAmt01013673
IRS990PF/Form990PFBalanceSheetsGrp/CashBOYAmt0287
IRS990PF/Form990PFBalanceSheetsGrp/CashEOYAmt01976
IRS990PF/Form990PFBalanceSheetsGrp/CashEOYFMVAmt01976
IRS990PF/Form990PFBalanceSheetsGrp/LandBldgEquipAccumDeprecAmt02968
IRS990PF/Form990PFBalanceSheetsGrp/LandBldgEquipCostOrOtherBssAmt03116
IRS990PF/Form990PFBalanceSheetsGrp/LandBOYAmt0443
IRS990PF/Form990PFBalanceSheetsGrp/LandEOYAmt0148
IRS990PF/Form990PFBalanceSheetsGrp/LandEOYFMVAmt0148
IRS990PF/Form990PFBalanceSheetsGrp/LoansFromOfficersBOYAmt0500000
IRS990PF/Form990PFBalanceSheetsGrp/LoansFromOfficersEOYAmt0500000
IRS990PF/Form990PFBalanceSheetsGrp/OrganizationFollowsSFAS117Ind0X
IRS990PF/Form990PFBalanceSheetsGrp/SavAndTempCashInvstBOYAmt0249095
IRS990PF/Form990PFBalanceSheetsGrp/SavAndTempCashInvstEOYAmt01011549
IRS990PF/Form990PFBalanceSheetsGrp/SavAndTempCashInvstEOYFMVAmt01011549
IRS990PF/Form990PFBalanceSheetsGrp/TotalAssetsBOYAmt0249825
IRS990PF/Form990PFBalanceSheetsGrp/TotalAssetsEOYAmt01013673
IRS990PF/Form990PFBalanceSheetsGrp/TotalAssetsEOYFMVAmt01013673
IRS990PF/Form990PFBalanceSheetsGrp/TotalLiabilitiesBOYAmt0500000
IRS990PF/Form990PFBalanceSheetsGrp/TotalLiabilitiesEOYAmt0500000
IRS990PF/Form990PFBalanceSheetsGrp/TotalLiabilitiesNetAstBOYAmt0249825
IRS990PF/Form990PFBalanceSheetsGrp/TotalLiabilitiesNetAstEOYAmt01013673
IRS990PF/Form990PFBalanceSheetsGrp/TotNetAstOrFundBalancesBOYAmt0-250175
IRS990PF/Form990PFBalanceSheetsGrp/TotNetAstOrFundBalancesEOYAmt0513673
IRS990PF/Form990PFBalanceSheetsGrp/UnrestrictedBOYAmt0-250175
IRS990PF/Form990PFBalanceSheetsGrp/UnrestrictedEOYAmt0513673
IRS990PF/MethodOfAccountingAccrualInd0X
IRS990PF/MinimumInvestmentReturnGrp/AcquisitionIndebtednessAmt00
IRS990PF/MinimumInvestmentReturnGrp/AdjustedTotalFMVOfUnusedAstAmt0631602
IRS990PF/MinimumInvestmentReturnGrp/AverageMonthlyCashBalancesAmt0631454
IRS990PF/MinimumInvestmentReturnGrp/AverageMonthlyFMVOfSecAmt00
IRS990PF/MinimumInvestmentReturnGrp/CashDeemedCharitableAmt09474
IRS990PF/MinimumInvestmentReturnGrp/FMVAllOtherNoncharitableAstAmt0148
IRS990PF/MinimumInvestmentReturnGrp/MinimumInvestmentReturnAmt031106
IRS990PF/MinimumInvestmentReturnGrp/NetVlNoncharitableAssetsAmt0622128
IRS990PF/MinimumInvestmentReturnGrp/ReductionClaimedAmt00
IRS990PF/MinimumInvestmentReturnGrp/TotalFMVOfUnusedAssetsAmt0631602
IRS990PF/OfficerDirTrstKeyEmplInfoGrp/CompOfHghstPdCntrctOrNONETxt0NONE
IRS990PF/OfficerDirTrstKeyEmplInfoGrp/CompOfHghstPdEmplOrNONETxt0NONE
IRS990PF/OfficerDirTrstKeyEmplInfoGrp/ContractorPaidOver50kCnt00
IRS990PF/OfficerDirTrstKeyEmplInfoGrp/OfficerDirTrstKeyEmplGrp/AverageHrsPerWkDevotedToPosRt040.00
IRS990PF/OfficerDirTrstKeyEmplInfoGrp/OfficerDirTrstKeyEmplGrp/AverageHrsPerWkDevotedToPosRt140.00
IRS990PF/OfficerDirTrstKeyEmplInfoGrp/OfficerDirTrstKeyEmplGrp/AverageHrsPerWkDevotedToPosRt21.00
IRS990PF/OfficerDirTrstKeyEmplInfoGrp/OfficerDirTrstKeyEmplGrp/AverageHrsPerWkDevotedToPosRt31.00
IRS990PF/OfficerDirTrstKeyEmplInfoGrp/OfficerDirTrstKeyEmplGrp/AverageHrsPerWkDevotedToPosRt41.00
IRS990PF/OfficerDirTrstKeyEmplInfoGrp/OfficerDirTrstKeyEmplGrp/AverageHrsPerWkDevotedToPosRt51.00
IRS990PF/OfficerDirTrstKeyEmplInfoGrp/OfficerDirTrstKeyEmplGrp/CompensationAmt0230000
IRS990PF/OfficerDirTrstKeyEmplInfoGrp/OfficerDirTrstKeyEmplGrp/CompensationAmt1202625
IRS990PF/OfficerDirTrstKeyEmplInfoGrp/OfficerDirTrstKeyEmplGrp/CompensationAmt20
IRS990PF/OfficerDirTrstKeyEmplInfoGrp/OfficerDirTrstKeyEmplGrp/CompensationAmt30
IRS990PF/OfficerDirTrstKeyEmplInfoGrp/OfficerDirTrstKeyEmplGrp/CompensationAmt40
IRS990PF/OfficerDirTrstKeyEmplInfoGrp/OfficerDirTrstKeyEmplGrp/CompensationAmt50
IRS990PF/OfficerDirTrstKeyEmplInfoGrp/OfficerDirTrstKeyEmplGrp/EmployeeBenefitProgramAmt00
IRS990PF/OfficerDirTrstKeyEmplInfoGrp/OfficerDirTrstKeyEmplGrp/EmployeeBenefitProgramAmt10
IRS990PF/OfficerDirTrstKeyEmplInfoGrp/OfficerDirTrstKeyEmplGrp/EmployeeBenefitProgramAmt20
IRS990PF/OfficerDirTrstKeyEmplInfoGrp/OfficerDirTrstKeyEmplGrp/EmployeeBenefitProgramAmt30
IRS990PF/OfficerDirTrstKeyEmplInfoGrp/OfficerDirTrstKeyEmplGrp/EmployeeBenefitProgramAmt40
IRS990PF/OfficerDirTrstKeyEmplInfoGrp/OfficerDirTrstKeyEmplGrp/EmployeeBenefitProgramAmt50
IRS990PF/OfficerDirTrstKeyEmplInfoGrp/OfficerDirTrstKeyEmplGrp/ExpenseAccountOtherAllwncAmt023315
IRS990PF/OfficerDirTrstKeyEmplInfoGrp/OfficerDirTrstKeyEmplGrp/ExpenseAccountOtherAllwncAmt119702
IRS990PF/OfficerDirTrstKeyEmplInfoGrp/OfficerDirTrstKeyEmplGrp/ExpenseAccountOtherAllwncAmt20
IRS990PF/OfficerDirTrstKeyEmplInfoGrp/OfficerDirTrstKeyEmplGrp/ExpenseAccountOtherAllwncAmt30
IRS990PF/OfficerDirTrstKeyEmplInfoGrp/OfficerDirTrstKeyEmplGrp/ExpenseAccountOtherAllwncAmt40
IRS990PF/OfficerDirTrstKeyEmplInfoGrp/OfficerDirTrstKeyEmplGrp/ExpenseAccountOtherAllwncAmt50
IRS990PF/OfficerDirTrstKeyEmplInfoGrp/OfficerDirTrstKeyEmplGrp/PersonNm0DR LEONARD RUIZ
IRS990PF/OfficerDirTrstKeyEmplInfoGrp/OfficerDirTrstKeyEmplGrp/PersonNm1SCOTT ROSENOW
IRS990PF/OfficerDirTrstKeyEmplInfoGrp/OfficerDirTrstKeyEmplGrp/PersonNm2DR FRANKLIN G PRENDERGAST
IRS990PF/OfficerDirTrstKeyEmplInfoGrp/OfficerDirTrstKeyEmplGrp/PersonNm3DR STEVEN G REED
IRS990PF/OfficerDirTrstKeyEmplInfoGrp/OfficerDirTrstKeyEmplGrp/PersonNm4DR RICHARD HAUGLAND
IRS990PF/OfficerDirTrstKeyEmplInfoGrp/OfficerDirTrstKeyEmplGrp/PersonNm5DR ER DICKSON
IRS990PF/OfficerDirTrstKeyEmplInfoGrp/OfficerDirTrstKeyEmplGrp/TitleTxt0PRESIDENT
IRS990PF/OfficerDirTrstKeyEmplInfoGrp/OfficerDirTrstKeyEmplGrp/TitleTxt1VP/TREASURER/SECRETARY
IRS990PF/OfficerDirTrstKeyEmplInfoGrp/OfficerDirTrstKeyEmplGrp/TitleTxt2CHAIRMAN
IRS990PF/OfficerDirTrstKeyEmplInfoGrp/OfficerDirTrstKeyEmplGrp/TitleTxt3DIRECTOR
IRS990PF/OfficerDirTrstKeyEmplInfoGrp/OfficerDirTrstKeyEmplGrp/TitleTxt4DIRECTOR
IRS990PF/OfficerDirTrstKeyEmplInfoGrp/OfficerDirTrstKeyEmplGrp/TitleTxt5DIRECTOR
IRS990PF/OfficerDirTrstKeyEmplInfoGrp/OfficerDirTrstKeyEmplGrp/USAddress/AddressLine1Txt0421 1ST AVENUE SW STE 304
IRS990PF/OfficerDirTrstKeyEmplInfoGrp/OfficerDirTrstKeyEmplGrp/USAddress/AddressLine1Txt1421 1ST AVENUE SW STE 304
IRS990PF/OfficerDirTrstKeyEmplInfoGrp/OfficerDirTrstKeyEmplGrp/USAddress/AddressLine1Txt2421 1ST AVENUE SW STE 304
IRS990PF/OfficerDirTrstKeyEmplInfoGrp/OfficerDirTrstKeyEmplGrp/USAddress/AddressLine1Txt3421 1ST AVENUE SW STE 304
IRS990PF/OfficerDirTrstKeyEmplInfoGrp/OfficerDirTrstKeyEmplGrp/USAddress/AddressLine1Txt4421 1ST AVENUE SW STE 304
IRS990PF/OfficerDirTrstKeyEmplInfoGrp/OfficerDirTrstKeyEmplGrp/USAddress/AddressLine1Txt5421 1ST AVENUE SW STE 304
IRS990PF/OfficerDirTrstKeyEmplInfoGrp/OfficerDirTrstKeyEmplGrp/USAddress/CityNm0ROCHESTER
IRS990PF/OfficerDirTrstKeyEmplInfoGrp/OfficerDirTrstKeyEmplGrp/USAddress/CityNm1ROCHESTER
IRS990PF/OfficerDirTrstKeyEmplInfoGrp/OfficerDirTrstKeyEmplGrp/USAddress/CityNm2ROCHESTER
IRS990PF/OfficerDirTrstKeyEmplInfoGrp/OfficerDirTrstKeyEmplGrp/USAddress/CityNm3ROCHESTER
IRS990PF/OfficerDirTrstKeyEmplInfoGrp/OfficerDirTrstKeyEmplGrp/USAddress/CityNm4ROCHESTER
IRS990PF/OfficerDirTrstKeyEmplInfoGrp/OfficerDirTrstKeyEmplGrp/USAddress/CityNm5ROCHESTER
IRS990PF/OfficerDirTrstKeyEmplInfoGrp/OfficerDirTrstKeyEmplGrp/USAddress/StateAbbreviationCd0MN
IRS990PF/OfficerDirTrstKeyEmplInfoGrp/OfficerDirTrstKeyEmplGrp/USAddress/StateAbbreviationCd1MN
IRS990PF/OfficerDirTrstKeyEmplInfoGrp/OfficerDirTrstKeyEmplGrp/USAddress/StateAbbreviationCd2MN
IRS990PF/OfficerDirTrstKeyEmplInfoGrp/OfficerDirTrstKeyEmplGrp/USAddress/StateAbbreviationCd3MN
IRS990PF/OfficerDirTrstKeyEmplInfoGrp/OfficerDirTrstKeyEmplGrp/USAddress/StateAbbreviationCd4MN
IRS990PF/OfficerDirTrstKeyEmplInfoGrp/OfficerDirTrstKeyEmplGrp/USAddress/StateAbbreviationCd5MN
IRS990PF/OfficerDirTrstKeyEmplInfoGrp/OfficerDirTrstKeyEmplGrp/USAddress/ZIPCd055902
IRS990PF/OfficerDirTrstKeyEmplInfoGrp/OfficerDirTrstKeyEmplGrp/USAddress/ZIPCd155902
IRS990PF/OfficerDirTrstKeyEmplInfoGrp/OfficerDirTrstKeyEmplGrp/USAddress/ZIPCd255902
IRS990PF/OfficerDirTrstKeyEmplInfoGrp/OfficerDirTrstKeyEmplGrp/USAddress/ZIPCd355902
IRS990PF/OfficerDirTrstKeyEmplInfoGrp/OfficerDirTrstKeyEmplGrp/USAddress/ZIPCd455902
IRS990PF/OfficerDirTrstKeyEmplInfoGrp/OfficerDirTrstKeyEmplGrp/USAddress/ZIPCd555902
IRS990PF/OfficerDirTrstKeyEmplInfoGrp/OtherEmployeePaidOver50kCnt00
IRS990PF/Organization501c3ExemptPFInd0X
IRS990PF/PrivateOperatingFoundationsGrp/GrossInvestmentIncomeGrp/TotalAmt00
IRS990PF/PrivateOperatingFoundationsGrp/LargestSupportFromEOGrp/TotalAmt00
IRS990PF/PrivateOperatingFoundationsGrp/LessorAdjNetIncmMinInvstRetGrp/CurrentYearAmt00
IRS990PF/PrivateOperatingFoundationsGrp/LessorAdjNetIncmMinInvstRetGrp/TotalAmt00
IRS990PF/PrivateOperatingFoundationsGrp/LessorAdjNetIncmMinInvstRetGrp/Year1Amt00
IRS990PF/PrivateOperatingFoundationsGrp/LessorAdjNetIncmMinInvstRetGrp/Year2Amt00
IRS990PF/PrivateOperatingFoundationsGrp/LessorAdjNetIncmMinInvstRetGrp/Year3Amt00
IRS990PF/PrivateOperatingFoundationsGrp/Pct85LessorAdjIncmOrMinRetGrp/CurrentYearAmt00
IRS990PF/PrivateOperatingFoundationsGrp/Pct85LessorAdjIncmOrMinRetGrp/TotalAmt00
IRS990PF/PrivateOperatingFoundationsGrp/Pct85LessorAdjIncmOrMinRetGrp/Year1Amt00
IRS990PF/PrivateOperatingFoundationsGrp/Pct85LessorAdjIncmOrMinRetGrp/Year2Amt00
IRS990PF/PrivateOperatingFoundationsGrp/Pct85LessorAdjIncmOrMinRetGrp/Year3Amt00
IRS990PF/PrivateOperatingFoundationsGrp/PublicSupportType/TotalAmt00
IRS990PF/PrivateOperatingFoundationsGrp/QualifyingDistributionsGrp/CurrentYearAmt0531925
IRS990PF/PrivateOperatingFoundationsGrp/QualifyingDistributionsGrp/TotalAmt01069659
IRS990PF/PrivateOperatingFoundationsGrp/QualifyingDistributionsGrp/Year1Amt0127766
IRS990PF/PrivateOperatingFoundationsGrp/QualifyingDistributionsGrp/Year2Amt0409968
IRS990PF/PrivateOperatingFoundationsGrp/QualifyingDistributionsGrp/Year3Amt00
IRS990PF/PrivateOperatingFoundationsGrp/QualifyingDistriMadeDrtGrp/CurrentYearAmt0531925
IRS990PF/PrivateOperatingFoundationsGrp/QualifyingDistriMadeDrtGrp/TotalAmt01069659
IRS990PF/PrivateOperatingFoundationsGrp/QualifyingDistriMadeDrtGrp/Year1Amt0127766
IRS990PF/PrivateOperatingFoundationsGrp/QualifyingDistriMadeDrtGrp/Year2Amt0409968
IRS990PF/PrivateOperatingFoundationsGrp/QualifyingDistriMadeDrtGrp/Year3Amt00
IRS990PF/PrivateOperatingFoundationsGrp/QualifyingDistriNotUsedDrtGrp/CurrentYearAmt00
IRS990PF/PrivateOperatingFoundationsGrp/QualifyingDistriNotUsedDrtGrp/TotalAmt00
IRS990PF/PrivateOperatingFoundationsGrp/QualifyingDistriNotUsedDrtGrp/Year1Amt00
IRS990PF/PrivateOperatingFoundationsGrp/QualifyingDistriNotUsedDrtGrp/Year2Amt00
IRS990PF/PrivateOperatingFoundationsGrp/QualifyingDistriNotUsedDrtGrp/Year3Amt00
IRS990PF/PrivateOperatingFoundationsGrp/Section4942j3Ind0X
IRS990PF/PrivateOperatingFoundationsGrp/TotalAssetsGrp/CurrentYearAmt01013673
IRS990PF/PrivateOperatingFoundationsGrp/TotalAssetsGrp/TotalAmt01610177
IRS990PF/PrivateOperatingFoundationsGrp/TotalAssetsGrp/Year1Amt0249825
IRS990PF/PrivateOperatingFoundationsGrp/TotalAssetsGrp/Year2Amt0346679
IRS990PF/PrivateOperatingFoundationsGrp/TotalAssetsSect4942j3BiGrp/CurrentYearAmt0178
IRS990PF/PrivateOperatingFoundationsGrp/TotalAssetsSect4942j3BiGrp/TotalAmt02448
IRS990PF/PrivateOperatingFoundationsGrp/TotalAssetsSect4942j3BiGrp/Year1Amt0443
IRS990PF/PrivateOperatingFoundationsGrp/TotalAssetsSect4942j3BiGrp/Year2Amt01827
IRS990PF/PrivateOperatingFoundationsGrp/TotalSupportGrp/TotalAmt00
IRS990PF/PrivateOperatingFoundationsGrp/TwoThirdsMinimumInvstRetGrp/TotalAmt00
IRS990PF/QlfyUndSect4940eReducedTaxGrp/AdjNetVlNoncharitableAssetsAmt0434324
IRS990PF/QlfyUndSect4940eReducedTaxGrp/AdjNonchrtblNetInvstIncmPctAmt0447282
IRS990PF/QlfyUndSect4940eReducedTaxGrp/AdjustedQlfyDistriYr1Amt0127766
IRS990PF/QlfyUndSect4940eReducedTaxGrp/AdjustedQlfyDistriYr2Amt0409968
IRS990PF/QlfyUndSect4940eReducedTaxGrp/AverageDistributionRt00.698126
IRS990PF/QlfyUndSect4940eReducedTaxGrp/DistributionYr1Rt00.435917
IRS990PF/QlfyUndSect4940eReducedTaxGrp/DistributionYr2Rt00.960335
IRS990PF/QlfyUndSect4940eReducedTaxGrp/LiableSection4942TaxInd00
IRS990PF/QlfyUndSect4940eReducedTaxGrp/NetInvestmentIncomePctAmt012958
IRS990PF/QlfyUndSect4940eReducedTaxGrp/NetVlNoncharitableAssetsAmt0622128
IRS990PF/QlfyUndSect4940eReducedTaxGrp/NetVlNoncharitableAssetsYr1Amt0293097
IRS990PF/QlfyUndSect4940eReducedTaxGrp/NetVlNoncharitableAssetsYr2Amt0426901
IRS990PF/QlfyUndSect4940eReducedTaxGrp/QualifyingDistributionsAmt0531925
IRS990PF/QlfyUndSect4940eReducedTaxGrp/TotalDistributionRt01.396252
IRS990PF/QualifyingDistriPartXIIGrp/AdjustedQualifyingDistriAmt0518967
IRS990PF/QualifyingDistriPartXIIGrp/CharitableAssetsAcquisPaidAmt00
IRS990PF/QualifyingDistriPartXIIGrp/ExpensesAndContributionsAmt0531925
IRS990PF/QualifyingDistriPartXIIGrp/PctSect4940eOrgNetInvstIncmAmt012958
IRS990PF/QualifyingDistriPartXIIGrp/ProgramRelatedInvstTotalAmt00
IRS990PF/QualifyingDistriPartXIIGrp/QualifyingDistributionsAmt0531925
IRS990PF/RlnOfActyToAccomOfExmptPrpsGrp/RlnOfActyToAccomOfExmptPrpsGrp/LineNumberTxt07
IRS990PF/RlnOfActyToAccomOfExmptPrpsGrp/RlnOfActyToAccomOfExmptPrpsGrp/LineNumberTxt17
IRS990PF/RlnOfActyToAccomOfExmptPrpsGrp/RlnOfActyToAccomOfExmptPrpsGrp/LineNumberTxt27
IRS990PF/RlnOfActyToAccomOfExmptPrpsGrp/RlnOfActyToAccomOfExmptPrpsGrp/RelationshipStatementTxt0RELATES TO THE DEVELOPMENT OF SAFE AND COST EFFECTIVE HEALTHCARE
IRS990PF/RlnOfActyToAccomOfExmptPrpsGrp/RlnOfActyToAccomOfExmptPrpsGrp/RelationshipStatementTxt1PRODUCTS AND ULTIMATELY FOR MAKING THOSE PRODUCTS AVAILABLE FOR
IRS990PF/RlnOfActyToAccomOfExmptPrpsGrp/RlnOfActyToAccomOfExmptPrpsGrp/RelationshipStatementTxt2FAMILIES IN NEED IN THE NEGLECTED POPULATIONS OF THE WORLD
IRS990PF/StatementsRegardingActy4720Grp/ActsFailToQlfyAsExceptionsInd00
IRS990PF/StatementsRegardingActy4720Grp/BrrwOrLendDisqualifiedPrsnInd00
IRS990PF/StatementsRegardingActy4720Grp/BusinessHoldingsInd00
IRS990PF/StatementsRegardingActy4720Grp/FurnGoodsDisqualifiedPrsnInd00
IRS990PF/StatementsRegardingActy4720Grp/GrantsToIndividualsInd00
IRS990PF/StatementsRegardingActy4720Grp/GrantsToOrganizationsInd00
IRS990PF/StatementsRegardingActy4720Grp/InfluenceElectionInd00
IRS990PF/StatementsRegardingActy4720Grp/InfluenceLegislationInd00
IRS990PF/StatementsRegardingActy4720Grp/JeopardyInvestmentsInd00
IRS990PF/StatementsRegardingActy4720Grp/NoncharitablePurposeInd00
IRS990PF/StatementsRegardingActy4720Grp/PayCompDisqualifiedPrsnInd01
IRS990PF/StatementsRegardingActy4720Grp/PaymentToGovernmentOfficialInd00
IRS990PF/StatementsRegardingActy4720Grp/PayPremiumsPrsnlBnftCntrctInd00
IRS990PF/StatementsRegardingActy4720Grp/ProhibitedTaxShelterTransInd00
IRS990PF/StatementsRegardingActy4720Grp/RcvFndsToPayPrsnlBnftCntrctInd00
IRS990PF/StatementsRegardingActy4720Grp/SaleOrExchDisqualifiedPrsnInd00
IRS990PF/StatementsRegardingActy4720Grp/TransferAstDisqualifiedPrsnInd00
IRS990PF/StatementsRegardingActy4720Grp/UncorrectedPriorActsInd00
IRS990PF/StatementsRegardingActy4720Grp/UncorrectedPYJeopardyInvstInd00
IRS990PF/StatementsRegardingActy4720Grp/UndistributedIncomePYInd00
IRS990PF/StatementsRegardingActyGrp/ActivitiesNotPreviouslyRptInd00
IRS990PF/StatementsRegardingActyGrp/AtLeast5000InAssetsInd01
IRS990PF/StatementsRegardingActyGrp/ChangesToArticlesOrBylawsInd00
IRS990PF/StatementsRegardingActyGrp/ComplyWithPublicInspRqrInd01
IRS990PF/StatementsRegardingActyGrp/DonorAdvisedFundInd00
IRS990PF/StatementsRegardingActyGrp/ForeignAccountsQuestionInd00
IRS990PF/StatementsRegardingActyGrp/Form1120POLFiledInd00
IRS990PF/StatementsRegardingActyGrp/Form990PFFiledWithAttyGenInd01
IRS990PF/StatementsRegardingActyGrp/LegislativePoliticalActyInd00
IRS990PF/StatementsRegardingActyGrp/LocationOfBooksUSAddress/AddressLine1Txt0421 1ST AVE SW SUITE 304
IRS990PF/StatementsRegardingActyGrp/LocationOfBooksUSAddress/CityNm0ROCHESTER
IRS990PF/StatementsRegardingActyGrp/LocationOfBooksUSAddress/StateAbbreviationCd0MN
IRS990PF/StatementsRegardingActyGrp/LocationOfBooksUSAddress/ZIPCd055902
IRS990PF/StatementsRegardingActyGrp/MoreThan100SpentInd00
IRS990PF/StatementsRegardingActyGrp/NewSubstantialContributorsInd00
IRS990PF/StatementsRegardingActyGrp/OrganizationDissolvedEtcInd00
IRS990PF/StatementsRegardingActyGrp/OrgReportOrRegisterStateCd0MN
IRS990PF/StatementsRegardingActyGrp/OwnControlledEntityInd00
IRS990PF/StatementsRegardingActyGrp/PersonsWithBooksName/BusinessNameLine1Txt0SCOTT ROSENOW
IRS990PF/StatementsRegardingActyGrp/PhoneNum05072064380
IRS990PF/StatementsRegardingActyGrp/PrivateOperatingFoundationInd01
IRS990PF/StatementsRegardingActyGrp/Section4955ManagersTaxAmt00
IRS990PF/StatementsRegardingActyGrp/Section4955OrganizationTaxAmt00
IRS990PF/StatementsRegardingActyGrp/Section508eRqrSatisfiedInd01
IRS990PF/StatementsRegardingActyGrp/TaxReimbursedAmt00
IRS990PF/StatementsRegardingActyGrp/UnrelatedBusIncmOverLimitInd00
IRS990PF/StatementsRegardingActyGrp/WebsiteAddressTxt0WWW.INTL-MEDICA.ORG
IRS990PF/SummaryOfDirectChrtblActyGrp/Description1Txt0THE PRIMARY PURPOSE OF INTL-MEDICA IS THE DEVELOPMENT AND DELIVERY OF AN ORAL ROTAVIRUS VACCINE FOR THE PREVENTION OF ROTAVIRUS-RELATED MORBIDITY AND DEATHS IN THE DEVELOPING WORLD. GLOBALLY, INFECTIONS FROM ROTAVIRUS ACCOUNT FOR AN ESTIMATED 125 MILLION CASES OF DIARRHEA EACH YEAR, RESULTING IN THE DEATHS OF APPROXIMATELY 500,000 INFANTS ANNUALLY FROM A DISEASE THAT IS HIGHLY PREVENTABLE WITH AN ORAL VACCINE. WORLDWIDE, ROTAVIRUS INFECTS EVERY CHILD IN THE WORLD IN THEIR FIRST FEW YEARS OF LIFE AND SENDS 1 CHILD IN EVERY 5 TO 8 TO A CLINIC FOR TREATMENT, 1 IN EVERY 58 TO A HOSPITAL, AND 1 IN 250-300 DIE FROM DEHYDRATING DIARRHEA. ROTAVIRUS IS THE CAUSE OF 30% TO 40% OF THE HOSPITALIZATIONS FOR DIARRHEA IN CHILDREN LESS THAN FIVE YEARS OF AGE AND RESULTS IN OVER 1,600 DEATHS EACH DAY IN DEVELOPING COUNTRIES WHERE MEDICAL CARE IS LIMITED AND MALNUTRITION IS PREVALENT. SEE CONTINUATION OF DIRECT CHARITABLE ACTIVITY #1 ON "GENERAL EXPLANATION ATTACHMENT"
IRS990PF/SummaryOfDirectChrtblActyGrp/Description2Txt0INTERNATIONAL MEDICA HAS BEEN WORKING WITH THE NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES (NIAID) NATIONAL INSTITUTES OF HEALTH (NIH), AND IDT BIOLOGIKA GMBH, ITS VACCINE MANUFACTURER IN GERMANY, ON A NEW, PROPRIETARY, LIQUID, HEAT-STABLE FORMULATION OF ROTASHIELD.A MAJOR CONSTRAINT IN ACHIEVING HIGH IMMUNIZATION RATES IN LESS-DEVELOPED COUNTRIES IS THE REQUIREMENT FOR A COLD CHAIN -- MAINTAINING PROPER REFRIGERATION OF THE VACCINE PRODUCT TO ENSURE ITS EFFECTIVENESS. THIS NEW ROTASHIELD LIQUID FORMULATION HAS THE POTENTIAL TO ELIMINATE THE NEED FOR A COLD CHAIN, WHICH WOULD SIGNIFICANTLY REDUCE THE DISTRIBUTION AND STORAGE COSTS OF THE VACCINE. ALL OF THE CURRENTLY MARKETED ROTAVIRUS VACCINES REQUIRE REFRIGERATION. ELIMINATION OF THE NEED FOR THE COLD-CHAIN FOR VACCINES IS ALSO OF GREAT INTEREST TO THE VACCINE COMMUNITY WORLDWIDE, ESPECIALLY IN THE DEVELOPING WORLD.SEE CONTINUATION OF DIRECT CHARITABLE ACTIVITY #2 ON "GENERAL EXPLANATION ATTACHMENT"
IRS990PF/SummaryOfDirectChrtblActyGrp/Description3Txt0MALARIA: THIS PAST YEAR THE FOUNDATION WORKED ON A MALARIA PROJECT WITH PURDUE UNIVERSITY AND A BIOSCIENCES COMPANY (HULOW LLC) TO DEVELOP A NEW MALARIA DRUG TREATMENT. THIS USED A DRUG FOR THE TREATMENT OF MALARIA, NOT A VACCINE, AND OUR ROLE IN THE PROJECT WAS TO POSITION THE DRUG FOR A "FIRST-USE-IN-MALARIA PATIENT" CLINICAL TRIAL. THE DRUG IS CURRENTLY AN FDA APPROVED DRUG AND IS WIDELY USED GLOBALLY FOR TREATING CANCER BUT HAS NEVER BEEN TESTED FOR ITS POTENTIAL TO TREAT MALARIA.SEE CONTINUATION OF DIRECT CHARITABLE ACTIVITY #3 ON "GENERAL EXPLANATION ATTACHMENT"
IRS990PF/SummaryOfDirectChrtblActyGrp/Description4Txt0WHILE THE ROTASHIELD VACCINE IS THE PRIMARY FOCUS OF THE FOUNDATION, INTERNATIONAL MEDICA CONTINUES TO ENGAGE IN DISCUSSIONS WITH RESEARCHERS AT THE NATIONAL INSTITUTE OF HEALTH (NIH), IN BETHESDA, MARYLAND, THE INFECTIOUS DISEASE RESEARCH INSTITUTE (IDRI) IN SEATTLE, WASHINGTON, THE UNIVERSITY OF MINNESOTA, AND THE MAYO CLINIC IN ROCHESTER, MINNESOTA, WITH REGARD TO POTENTIAL VACCINES TO BE DEVELOPED AND OTHER POSSIBLE GLOBAL DISEASE ISSUES TO BE ADDRESSED. THE FOUNDATION IS ACTIVELY EXAMINING THE POSSIBILITIES OF LICENSING AND DEVELOPING A VACCINE FOR WEST NILE VIRUS, HAEMOPHILUS INFLUENZAE SEROTYPE A (HIA) AND CHIKUNGUNYA VIRUS (CHIKV).
IRS990PF/SummaryOfDirectChrtblActyGrp/Expenses1Amt0159228
IRS990PF/SummaryOfDirectChrtblActyGrp/Expenses2Amt0154879
IRS990PF/SummaryOfDirectChrtblActyGrp/Expenses3Amt0127412
IRS990PF/SummaryOfDirectChrtblActyGrp/Expenses4Amt0100407
IRS990PF/SumOfProgramRelatedInvstGrp/TotalAmt00
IRS990PF/SupplementaryInformationGrp/ContributingManagerNm0DR RICHARD HAUGLAND
IRS990PF/SupplementaryInformationGrp/OnlyContriToPreselectedInd0X
IRS990PF/SupplementaryInformationGrp/TotalGrantOrContriApprvFutAmt00
IRS990PF/SupplementaryInformationGrp/TotalGrantOrContriPdDurYrAmt00
IRS990PF/TrnsfrTransRlnNonchrtblEOGrp/LoansOrLoanGuaranteesInd00
IRS990PF/TrnsfrTransRlnNonchrtblEOGrp/PerformanceOfServicesEtcInd00
IRS990PF/TrnsfrTransRlnNonchrtblEOGrp/PurchaseOfAssetsNonchrtblEOInd00
IRS990PF/TrnsfrTransRlnNonchrtblEOGrp/ReimbursementArrangementsInd00
IRS990PF/TrnsfrTransRlnNonchrtblEOGrp/RelationshipsNonchrtblEOInd00
IRS990PF/TrnsfrTransRlnNonchrtblEOGrp/RentalOfFacilitiesOthAssetsInd00
IRS990PF/TrnsfrTransRlnNonchrtblEOGrp/SalesOrExchangesOfAssetsInd00
IRS990PF/TrnsfrTransRlnNonchrtblEOGrp/SharingOfFacilitiesEtcInd00
IRS990PF/TrnsfrTransRlnNonchrtblEOGrp/TrnsfrOfCashToNonchrtblEOInd00
IRS990PF/TrnsfrTransRlnNonchrtblEOGrp/TrnsfrOtherAssetNonchrtblEOInd00
LandEtcSchedule2/LandEtcGrp/AccumulatedDepreciationAmt01126
LandEtcSchedule2/LandEtcGrp/AccumulatedDepreciationAmt11842
LandEtcSchedule2/LandEtcGrp/BookValueAmt00
LandEtcSchedule2/LandEtcGrp/BookValueAmt1148
LandEtcSchedule2/LandEtcGrp/CategoryOrItemTxt0SONY COMPUTER
LandEtcSchedule2/LandEtcGrp/CategoryOrItemTxt1LENOVO COMPUTER
LandEtcSchedule2/LandEtcGrp/CostOrOtherBasisAmt01126
LandEtcSchedule2/LandEtcGrp/CostOrOtherBasisAmt11990
LegalFeesSchedule/LegalFeesGrp/AdjustedNetIncomeAmt00
LegalFeesSchedule/LegalFeesGrp/CategoryTxt0LEGAL SERVICES
LegalFeesSchedule/LegalFeesGrp/DisbursementsCharitablePrpsAmt022606
LegalFeesSchedule/LegalFeesGrp/LegalFeesAmt022606
LegalFeesSchedule/LegalFeesGrp/NetInvestmentIncomeAmt00
OtherExpensesSchedule/OtherExpensesScheduleGrp/AdjustedNetIncomeAmt00
OtherExpensesSchedule/OtherExpensesScheduleGrp/AdjustedNetIncomeAmt10
OtherExpensesSchedule/OtherExpensesScheduleGrp/AdjustedNetIncomeAmt20
OtherExpensesSchedule/OtherExpensesScheduleGrp/AdjustedNetIncomeAmt30
OtherExpensesSchedule/OtherExpensesScheduleGrp/AdjustedNetIncomeAmt40
OtherExpensesSchedule/OtherExpensesScheduleGrp/Desc0INSURANCE
OtherExpensesSchedule/OtherExpensesScheduleGrp/Desc1OFFICE SUPPLIES AND EXPENSE
OtherExpensesSchedule/OtherExpensesScheduleGrp/Desc2INCOME TAXES
OtherExpensesSchedule/OtherExpensesScheduleGrp/Desc3INFORMATION TECHNOLOGY
OtherExpensesSchedule/OtherExpensesScheduleGrp/Desc4NATIONAL INSTITUTE OF HEALTH (NIH) FEES
OtherExpensesSchedule/OtherExpensesScheduleGrp/DisbursementsCharitablePrpsAmt02505
OtherExpensesSchedule/OtherExpensesScheduleGrp/DisbursementsCharitablePrpsAmt15517
OtherExpensesSchedule/OtherExpensesScheduleGrp/DisbursementsCharitablePrpsAmt20
OtherExpensesSchedule/OtherExpensesScheduleGrp/DisbursementsCharitablePrpsAmt3552
OtherExpensesSchedule/OtherExpensesScheduleGrp/DisbursementsCharitablePrpsAmt482582
OtherExpensesSchedule/OtherExpensesScheduleGrp/NetInvestmentIncomeAmt0626
OtherExpensesSchedule/OtherExpensesScheduleGrp/NetInvestmentIncomeAmt11348
OtherExpensesSchedule/OtherExpensesScheduleGrp/NetInvestmentIncomeAmt26000
OtherExpensesSchedule/OtherExpensesScheduleGrp/NetInvestmentIncomeAmt3138
OtherExpensesSchedule/OtherExpensesScheduleGrp/NetInvestmentIncomeAmt40
OtherExpensesSchedule/OtherExpensesScheduleGrp/RevenueAndExpensesPerBooksAmt03131
OtherExpensesSchedule/OtherExpensesScheduleGrp/RevenueAndExpensesPerBooksAmt16865
OtherExpensesSchedule/OtherExpensesScheduleGrp/RevenueAndExpensesPerBooksAmt26000
OtherExpensesSchedule/OtherExpensesScheduleGrp/RevenueAndExpensesPerBooksAmt3690
OtherExpensesSchedule/OtherExpensesScheduleGrp/RevenueAndExpensesPerBooksAmt482582
OtherIncomeSchedule2/OtherIncomeDetail/AdjustedNetIncomeAmt00
OtherIncomeSchedule2/OtherIncomeDetail/Desc0ROYALTIES
OtherIncomeSchedule2/OtherIncomeDetail/NetInvestmentIncomeAmt01405419
OtherIncomeSchedule2/OtherIncomeDetail/RevenueAndExpensesPerBooksAmt01405419
OtherProfessionalFeesSchedule/OtherProfessionalFeesDetail/AdjustedNetIncomeAmt00
OtherProfessionalFeesSchedule/OtherProfessionalFeesDetail/Amt01293
OtherProfessionalFeesSchedule/OtherProfessionalFeesDetail/CategoryTxt0PAYROLL PROCESSING SERVICE
OtherProfessionalFeesSchedule/OtherProfessionalFeesDetail/DisbursementsCharitablePrpsAmt01034

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings